1. Home
  2. AZTR vs DGLY Comparison

AZTR vs DGLY Comparison

Compare AZTR & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • DGLY
  • Stock Information
  • Founded
  • AZTR 2014
  • DGLY 2004
  • Country
  • AZTR United States
  • DGLY United States
  • Employees
  • AZTR N/A
  • DGLY N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • AZTR Health Care
  • DGLY Technology
  • Exchange
  • AZTR Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • AZTR 4.0M
  • DGLY 3.9M
  • IPO Year
  • AZTR 2023
  • DGLY N/A
  • Fundamental
  • Price
  • AZTR $0.22
  • DGLY $2.04
  • Analyst Decision
  • AZTR
  • DGLY
  • Analyst Count
  • AZTR 0
  • DGLY 0
  • Target Price
  • AZTR N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • AZTR 798.9K
  • DGLY 87.5K
  • Earning Date
  • AZTR 08-11-2025
  • DGLY 08-15-2025
  • Dividend Yield
  • AZTR N/A
  • DGLY N/A
  • EPS Growth
  • AZTR N/A
  • DGLY N/A
  • EPS
  • AZTR N/A
  • DGLY N/A
  • Revenue
  • AZTR $7,500.00
  • DGLY $18,596,715.00
  • Revenue This Year
  • AZTR N/A
  • DGLY N/A
  • Revenue Next Year
  • AZTR N/A
  • DGLY N/A
  • P/E Ratio
  • AZTR N/A
  • DGLY N/A
  • Revenue Growth
  • AZTR N/A
  • DGLY N/A
  • 52 Week Low
  • AZTR $0.21
  • DGLY $1.91
  • 52 Week High
  • AZTR $1.25
  • DGLY $217.00
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 37.04
  • DGLY 26.58
  • Support Level
  • AZTR $0.22
  • DGLY $1.91
  • Resistance Level
  • AZTR $0.24
  • DGLY $2.11
  • Average True Range (ATR)
  • AZTR 0.01
  • DGLY 0.12
  • MACD
  • AZTR -0.00
  • DGLY 0.49
  • Stochastic Oscillator
  • AZTR 7.97
  • DGLY 31.71

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: